Coloplast A/S: financial analysis
Ratios worked out from 2 fiscal years of Coloplast A/S's statements, compared with 53 companies in Medical Instruments.
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | Median of peers | Ahead of |
|---|---|---|---|---|---|
| Equity share of assets | 28.5% | 34.4% | 57.0% | 17% |
How each figure is worked out#
- Equity share of assets
- Shareholders' equity as a share of total assets.
Source: Coloplast A/S's statements: annual reports in the European single electronic format. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). "Ahead of" is the share of the 53 companies in Medical Instruments that Coloplast A/S is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to Coloplast A/S